Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-24 @ 6:49 PM
NCT ID:
NCT05744557
Eligibility Criteria:
Inclusion Criteria:
* Any adult patient undergoing asubareolar breast lymphoscintigraphy injection will be eligible.
* Age ≥18 years old
* Ability to understand and the willingness to sign a written informed consent document.
* Childbearing potential, lactating, pregnant women will be included.
Exclusion Criteria:
* Patients who have allergy or had prior hypersensitivity to either of the vapocoolants including 1,1,1,3,3 Pentafluoropropane and 1,1,1,2-Tetrafluoroethane.
* Patients with uncontrolled intercurrent illness (insulin dependent and non-insulin dependent diabetes)
* Patients with psychiatric illness/social situations that would limit compliance with study requirements.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05744557
Study Brief:
Protocol Section:
NCT05744557